Literature DB >> 6414003

The effect of d-amphetamine and haloperidol alone and in combination on milk drinking in rats.

R W Foltin, W L Woolverton, C R Schuster.   

Abstract

The effects of d-amphetamine (0.5-4.0 mg/kg IP) and haloperidol (0.015-1.0 mg/kg IP) alone and in combination on intake of a sweetened milk solution were determined in rats. Experimental sessions consisted of a 15-min access to the milk solution once a day, 7 days a week. d-Amphetamine was administered 15 min prior to the session and haloperidol was administered 60 min prior to the session. The interaction of these compounds was determined by repeated determination of the dose-response function for d-amphetamine in combination with different doses of haloperidol. When given alone, each drug produced a dose-dependent decrease in milk intake. In combination with haloperidol, the decrement caused by d-amphetamine was shifted to lower doses in a dose-dependent manner. Isobolographic analysis of the interaction indicates that the intermediate doses (0.03-0.06 mg/kg) of haloperidol were additive and the highest doses (0.12-0.25 mg/kg) of haloperidol were infraadditive with d-amphetamine. Dose-dependent neuropharmacological actions of these compounds may account for dose-dependent interactions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414003     DOI: 10.1007/BF00432117

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

2.  The roles of monoamine neural systems in the anorexia induced by(+)-amphetamine and related compounds.

Authors:  A S Hollister; G N Ervin; B R Cooper; G R Breese
Journal:  Neuropharmacology       Date:  1975-10       Impact factor: 5.250

3.  Antagonism of responses to anorectics by selective receptor blockers [proceedings].

Authors:  Z L Kruk; L A Smith; M R Zarrindast
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

4.  On the central mediation of anorexigenic drug effects.

Authors:  H H Frey; R Schulz
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  Role of catecholamines in the anorectic effects of amphetamine in rats.

Authors:  L A Baez
Journal:  Psychopharmacologia       Date:  1974-02-15

6.  A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol.

Authors:  P K Gessner; B E Cabana
Journal:  J Pharmacol Exp Ther       Date:  1970-08       Impact factor: 4.030

7.  Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor.

Authors:  B K Yeh; J L McNay; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1969-08       Impact factor: 4.030

8.  Measurement of the potencies of drug mixtures.

Authors:  P S Hewlett
Journal:  Biometrics       Date:  1969-09       Impact factor: 2.571

9.  The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats.

Authors:  T G Heffner; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

10.  Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.

Authors:  T G Heffner; M J Zigmond; E M Stricker
Journal:  J Pharmacol Exp Ther       Date:  1977-05       Impact factor: 4.030

View more
  2 in total

1.  Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.

Authors:  Davide Amato; Maria Antonietta Stasi; Franco Borsini; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2008-07-03       Impact factor: 4.530

2.  The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat.

Authors:  Michele S Milella; Davide Amato; Aldo Badiani; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2008-01-12       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.